Mifentidine
Alternative Names: DA 4577Latest Information Update: 17 Oct 2003
At a glance
- Originator Boehringer Ingelheim
- Class Antihistamines; Antiulcers
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Duodenal ulcer
Most Recent Events
- 17 Nov 1998 Discontinued - Phase-II for Duodenal ulcers in Germany